[Treatment of toxoplasmosis in women].
D005260:Female; D006801:Humans; D007933:Leucomycins / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011739:Pyrimethamine / Q000627:therapeutic use; D013412:Sulfadimethoxine / Q000627:therapeutic use*; D014123:Toxoplasmosis / Q000188:drug therapy*
D007933:Leucomycins; D013412:Sulfadimethoxine; D011739:Pyrimethamine
Wstepna ocena leczenia toksoplazmozy u kobiet.